QLRAD International Ltd.

QLRAD is a medical device manufacturer specializing in the development, design, and assembly of innovative products for radiotherapy and urology applications. The company serves over 100 healthcare organizations worldwide with a focus on precision medical devices that support diagnostic and therapeutic workflows. Primary product lines include endorectal balloons (RectalPro) designed for reproducible positioning and patient comfort in radiotherapy procedures, goldmarkers and fiducial needles used in image-guided interventions and brachytherapy, and breast immobilization devices (IMF Breast Wedge) utilized in radiation oncology positioning and treatment planning. QLRAD maintains manufacturing and distribution capabilities across multiple regions including the USA, Cyprus (International headquarters), and the Netherlands, ensuring global accessibility and compliance with regional regulatory requirements. The company demonstrates clinical engagement through participation in major professional conferences (ASRT, AAPM) and publication of clinical data supporting product efficacy and safety. Products are designed to enhance procedural accuracy, reproducibility, and patient tolerability in specialized medical applications.